Classification of the Tumor Immune Microenvironment Using Machine-Learning-Based CD8 Immunophenotyping As a Potential Biomarker for Immunotherapy and TGF-β Blockade in Nonsmall Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Classification of the Tumor Immune Microenvironment Using Machine-Learning-Based CD8 Immunophenotyping As a Potential Biomarker for Immunotherapy and TGF-β Blockade in Nonsmall Cell Lung Cancer

Published:2024-04-01 Issue:2 Volume:1 Page:106-118
ISSN:2993-091X
Container-title:AI in Precision Oncology
language:en
Short-container-title:AI in Precision Oncology

Author:

Pomponio Robert J.¹,Wang Hong¹,Bean Sarah Mitchell¹,Tang Qi¹,Trullo Roger¹,Lee Joon Sang¹,Demers Brigitte²,Khosla Archit³,Stanford-Moore Adam³,Guramare Maria³,Hedvat Cyrus³,Brutus Sergine³,Wang Rui¹

Affiliation:

1. Sanofi, Cambridge, Massachusetts, USA.

2. Sanofi, Vitry-sur-Seine, France.

3. PathAI, Boston, Massachusetts, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/aipo.2023.0008

Reference59 articles.

1. Cancer Progress and Priorities: Lung Cancer

2. A framework for understanding and targeting residual disease in oncogene-driven solid cancers

3. Lung cancer

4. Immune Checkpoint Blockade in Cancer Therapy

5. FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP